Market News & Trends
Aravive & WuXi Biologics Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies
Aravive, Inc. and WuXi Biologics recently announced a strategic collaboration agreement granting Aravive the right to use the proprietary WuXiBody platform to develop high-affinity bispecific…
TTP Collaborates With ODx to Develop New Technology to Address Antibiotic Resistance
TTP plc recently announced it has partnered with ODx (ODx Innovations Ltd), a company committed to developing a system for assessing urinary tract infections (UTIs).…
FDA Approves FENSOLVI for Injectable Suspension for Pediatric Patients with Central Precocious Puberty
Tolmar Pharmaceuticals, Inc. recently announced the US FDA has approved its New Drug Application for FENSOLVI (leuprolide acetate) for injectable suspension for the treatment of…
Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership With CytoDyn
Ajinomoto Bio-Pharma Services recently announced it has entered into a manufacturing services agreement with CytoDyn Inc., a late stage biotechnology company, for the supply of the investigational new drug….
Arcturus Therapeutics & Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
Arcturus Therapeutics Holdings Inc. and Catalent, Inc.recently announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended to….
Valneva & Pfizer Announce Collaboration to Co-Develop & Commercialize Vaccine
Valneva SE (Valneva) recently announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine candidate….
3M Drug Delivery Systems Launches as Independent Company, Kindeva Drug Delivery
Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, recently announced its launch as an independent company following the acquisition by Altaris Capital Partners in a transaction valued at….
Adare Pharmaceuticals Acquires Orbis Biosciences
Adare Pharmaceuticals, Inc. recently announced it has acquired the pharmaceutical technology company, Orbis Biosciences, Inc. The acquisition of Orbis will….
Almac Group’s Comprehensive Service Offerings to Support Expedited COVID-19 Research Programs & Treatments
Almac Group is an established contract development and manufacturing organization (CDMO) providing an extensive range of integrated services across the drug development lifecycle to the…
Quotient Sciences & CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm
A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was recently announced today by Quotient Sciences, a leading…
WEBINAR - Developing an Oral Modified-Release (MR) Formulation: Challenges & Considerations for Achieving Success
Please join Quotient Sciences’ Vice President of Pharmaceutical Sciences, Dr. Andy Lewis, on May 20 at 10 AM London/11 AM Brussels or 6 PM London/1 PM New York for a live webinar on modified-release formulation…
Mitsubishi Chemical to Bolster Technology Platform Through Acquisition of American Organic & Inorganic Hybrid Chemicals
Mitsubishi Chemical Corporation recently announced its subsidiary Mitsubishi Chemical America, Inc. has entered into a definitive agreement to acquire all of the issued and….
Trio Pharmaceuticals & Ajinomoto Bio-Pharma Services Enter Development Collaboration for a Novel Antibody Therapeutic
Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services recently announced a development collaboration agreement to evaluate AJICAP, a proprietary site-specific conjugation technology offered by…
Stevanato Group Announces Product Development Collaboration With Cambridge Design Partnership on Pen-Injector Technology
Stevanato Group, a leading producer of glass primary packaging and provider of integrated capabilities for combination products and Cambridge Design Partnership (CDP), a UK- and US-based leading technology and product design partner, recently….
Avadel Pharmaceuticals Announces Positive Topline Results from its Pivotal Phase 3 REST-ON Trial
Avadel Pharmaceuticals plc recently announced positive topline data from its pivotal Phase 3 REST-ON trial assessing the safety and efficacy of FT218, an investigational, once-nightly…
Amphastar Pharmaceuticals Receives FDA Approval for Epinephrine Injection
Amphastar Pharmaceuticals, Inc. recently announced the US FDA has granted approval of its Abbreviated New Drug Application (ANDA) for Epinephrine Injection, USP 30 mg/30 mL…
Orchard Therapeutics Announces First Patient Dosed with OTL-201 Gene Therapy
Orchard Therapeutics recently announced that the first patient has been dosed in an open-label, proof-of-concept investigational study of OTL-201, an ex vivo autologous hematopoietic stem cell…
Harpoon Therapeutics Doses First Patient with HPN217, a BCMA Targeting TriTAC, for Multiple Myeloma
Harpoon Therapeutics, Inc. recently announced the first patient has been dosed with HPN217 in a Phase 1/2 clinical trial focused on relapsed, refractory multiple myeloma…
BioAegis Demonstrates Gelsolin Therapy Can Quell the COVID-19 Cytokine Storm & Promote Tissue Repair
BioAegis Therapeutics Inc. has highlighted recently published gene expression data in animal studies in which recombinant human plasma gelsolin (rhu-pGSN) significantly increased survival in pneumonia…
Santhera & Cold Spring Harbor Laboratory to Investigate Lonodelestat in COVID-19-Related ARDS
Santhera Pharmaceuticals recently announced it has entered into a collaboration agreement with Cold Spring Harbor Laboratory (CSHL) to investigate the potential of lonodelestat (POL6014), a…
